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Abstract 
Xylitol has been claimed to reduce mutans streptococci (MS) in dental plaque by energy-
consuming futile metabolic cycles. This study aimed to investigate effects of xylitol on MS in 
an in vitro six-species oral biofilm model. Each multispecies biofilm contained either a 
laboratory reference strain, a fresh isolate, a xylitol-sensitive or a xylitol-resistant strain of 
Streptococcus mutans or Streptococcus sobrinus. Biofilms, grown on pellicle-coated 
hydroxyapatite discs, were fed with a glucose/sucrose-supplemented medium three times 
daily for 45 min and incubated in saliva between feedings. Before or after feeding, biofilms 
were exposed to either 7.5% xylitol, 7.5% sorbitol or to saliva (control) for 20 min. After 64.5 
h biofilms were harvested and the microbial composition was analyzed by non-selective and 
selective culturing. Strain variability in the ability to colonize biofilms was observed. 
However, the response patterns in the biofilms to the four polyol treatments were similar. 
None of the MS were inhibited by xylitol provided either before or after feeding. Sorbitol 
given before feeding did not affect microbial growth whereas sorbitol provided after feeding 
showed a slight, albeit statistically significant increase in MS counts for some of the tested 
strains. It did so at the expense of Streptococcus oralis, which decreased in numbers. The 
present findings do not support the contention that xylitol reduces MS in plaque by futile 
metabolic cycles.  
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Introduction 
The naturally occurring sugar alcohols xylitol and sorbitol, and combinations thereof, 
have been widely used as sugar substitutes in chewing gums and confectionary products [Bär, 
1988; Birkhed and Bär, 1991; Bowen, 1996; Van Loveren, 2004]. Xylitol is non-cariogenic 
since it is not fermented by most oral microorganisms and does not give rise to acid formation 
in dental plaque [Edwardsson et al., 1977; Birkhed and Edwardsson, 1978; Havenaar et al., 
1978; Hayes and Roberts, 1978; Bär, 1988; Van Loveren, 2004]. Sorbitol is slowly fermented 
by comparatively few microorganisms in plaque [Edwardsson et al., 1977; Havenaar et al., 
1978; Kalfas and Edwardsson, 1990], and products formulated with sorbitol are accepted as 
being non-cariogenic [Birkhed and Bär, 1991; Bowen, 1996; Van Loveren, 2004].  
Besides its non-cariogenicity, xylitol has attracted much attention as a caries-
preventive or even caries-therapeutic agent. The mechanisms behind these disputed properties 
have yet to be defined. It has been claimed that xylitol reduces the acidogenic potential of 
plaque, suppresses growth of  plaque bacteria, notably of mutans streptococci (MS), enhances 
salivation and promotes remineralization of dental hard tissues [Tanzer, 1995; Twetman and 
Holgerson, 2004].  
The inhibtory effects of xylitol on oral microorganisms have been attributed mainly to 
its interference with MS [Bär, 1988; Tanzer, 1995; Trahan, 1995]. The mechanism of action 
was suggested to be an energy-consuming cycle related to the uptake and phosphorylation of 
xylitol to xylitol 5-phosphate and the subsequent dephosphorylation and expulsion of xylitol 
[Assev and Rølla, 1984; Trahan et al., 1985; Assev and Rølla, 1986; Trahan et al., 1991]. 
Intracellular accumulation of xylitol 5-phosphate conceivably leads to inhibition of bacterial 
glycolytic enzymes, resulting in impaired growth and acid production, as well as an ecological 
selection towards xylitol-resistant (X-R) MS in plaque [Assev and Rølla, 1984; Trahan et al., 
1985; Assev and Rølla, 1986; Trahan and Mouton, 1987; Trahan et al., 1991, 1992; Trahan, 
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1995]. The X-R strains seem to become inert to xylitol, so that their glycolysis is no longer 
inhibited by xylitol [Gauthier et al., 1984].  
It is well documented that the continuous presence of xylitol in the culture medium of 
planktonically grown monocultures inhibits the in vitro growth of MS and some other oral 
bacterial species [Assev et al., 1983; Assev and Rølla, 1984; Trahan et al., 1985; Assev and 
Rølla, 1986; Trahan et al., 1991]. An intriguing question is, however, whether the so-called 
“futile xylitol cycle” – uptake and expulsion of xylitol under expenditure of energy – operates 
in dental plaque. This has not been substantiated. A previously developed mixed-six-species 
biofilm model of supragingival plaque based on a batch culture approach [van der Ploeg and 
Guggenheim, 2004; Thurnheer et al., 2006] seemed to be a valuable tool to investigate the 
effects of xylitol on survival of MS in biofilms containing various strains of xylitol-sensitive 
(X-S), X-R, fresh isolates or laboratory types of MS. For comparison, sorbitol was included as 
an additional test substance since it is only slowly metabolized by some oral microorganisms 
without any claims of “specific effects” as a cariostatic agent [Birkhed and Bär, 1991; Bowen, 
1996; Van Loveren, 2004]. The aim of the present study was to test the hypothesis that 
repeated exposures of mixed-six-species oral biofilms in vitro to xylitol reduce the numbers of 
MS through futile metabolic cycles.  
 
Material and Methods 
Inoculum and media preparation 
A modification of the Zürich in vitro model of supragingival plaque [Guggenheim et 
al., 2001] was adopted in this experiment. For biofilm formation, the following species were 
used: Actinomyces naeslundii (OMZ 745), Candida albicans (OMZ 110), Fusobacterium 
nucleatum (OMZ 596), Streptococcus oralis (SK 248), Veillonella dispar (ATCC 17748) and 
one of the MS listed in table 1. 
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All strains were cultivated on Columbia Blood Agar (Difco, Sparks, MD, USA). 
Colonies of each strain were transferred to 9 ml of modified fluid universal medium (mFUM) 
containing 0.3% of glucose (plus 1% sodium lactate, for V. dispar) and anaerobically 
incubated at 37 ºC. mFUM corresponds to a well established tryptone-yeast based broth 
medium designated as FUM [Gmür and Guggenheim, 1983] and modified by supplementing 
67 mmol/l Sørensen’s buffer (final pH 7.2). After approximately 15 h of incubation, 200 µl of 
each suspension were transferred to 5 ml of a fresh mFUM (containing 0.3% glucose) and 
further incubated until an optical density of 1.0 ± 0.02 at 550 nm was reached. Aliquots from 
A. naeslundii, C. albicans, F. nucleatum, S. oralis, V. dispar and one of the S. mutans or S. 
sobrinus strains (table 1), were combined, in order to form a standardized mixed-six-species 
suspension, and stored on ice until the onset of the biofilm experiment [Guggenheim et al., 
2001]. In all steps mentioned above, the C. albicans strain was incubated in 10% CO2.    
The biofilms were formed on sterile hydroxyapatite discs (Ø 10.6 mm; Clarkson 
Chemical Company, Williamsport, PA, USA). For each mixed-six-species biofilm 
experiment, 15 hydroxyapatite discs were used. In order to form a salivary pellicle on the 
surface of the discs, they were placed in 24-well polystyrene cell culture plates and covered 
with 1600 µl of processed saliva prepared as described previously [Guggenheim et al., 2001]. 
During pellicle formation the plates were gently shaken at room temperature for 4 h.  
 
Time flow of “feast and famine” biofilm experiments 
An overall survey of the time flow of each biofilm experiment is provided in fig. 1. 
Throughout this study, a “feast and famine” protocol [van der Ploeg and Guggenheim, 2004; 
Thurnheer et al., 2006] was adopted. After salivary pellicle formation, saliva was replaced at 
time 0 h with a mixture of processed saliva (480 µl) and mFUM (1120 µl) containing 0.3% 
glucose (fig. 1). In each well, a volume of 200 µl of mixed-six-species suspension was added 
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and the culture plate was anaerobically incubated at 37 ºC for 45 min. Then, the discs were 
dip-washed three times in physiological saline, transferred to new wells containing 1600 µl 
fresh processed saliva and incubated anaerobically at 37 ºC up to time point 16.5 h (period of 
famine). At time points 16.5 h, 20.5 h, 24.5 h, 40.5 h, 44.5 h, and 48.5 h all discs were re-
exposed for 45 min to a cell-free mixture of processed saliva (480 µl) and mFUM (1120 µl) 
with 0.15% glucose + 0.15% sucrose (periods of feast), after which they were dip-washed as 
described above and transferred back into processed saliva (famine). After the feeding periods 
starting at 16.5 h, 20.5 h, 40.5 h, and 44.5 h the discs were put back into the same processed 
saliva provided before feeding, whereas after the feeding periods starting at 24.5 h and 48.5 h 
the discs were transferred to new plates with fresh processed saliva. Experiments were 
stopped and biofilms analysed after 64.5 h of incubation. Exposures to polyols lasted for 20 
min and occurred immediately before or immediately after feeding periods as described in the 
next section. 
 
Exposure of biofilms to polyol solutions 
Figure 2 provides a schematic overview of the allocation of biofilms to the different 
treatments within one experiment. Every experiment covered one of the eight mutans strains 
and included triplicate biofilms for each treatment. In order to evaluate the effect of the 
polyols on starved biofilms three discs were exposed anaerobically (37 °C, 20 min) before 
each feeding period to a mixture of processed saliva (480 µl) and water (1120 µl) containing 
either 7.5% xylitol (discs 4-6) or 7.5% sorbitol (discs 7-9). These polyol percentages indicate 
final concentrations in the entire 1600 µl. During this time the remaining nine discs (discs 1-3, 
10-15) were put into a corresponding mixture of fresh processed saliva and water. Thereafter, 
the biofilms were 3x dip-washed in saline and then transferred to new wells for the feeding 
period.  
 8 
To evaluate the effect of polyols on MS after feeding, another three discs were 
transferred to a fresh mixture of processed saliva and water with either 7.5% xylitol (discs 10-
12) or 7.5% sorbitol (discs 13-15)  (fig. 2), while all remaining discs were switched to 
processed saliva/water as described above. After 20 min of anaerobic incubation at 37 ºC, all 
discs were dip-washed again three times in physiological saline, transferred to new wells 
containing processed fresh saliva and incubated anaerobically at 37 ºC (next famine period). 
During the entire experiment three control discs (discs 1-3) were never exposed to polyol 
solutions (fig. 2). 
In total, 120 biofilms were used in this study: eight types of biofilm each with a 
different strain of MS, five treatments per biofilm type (control, xylitol and sorbitol before 
and after feeding), and three replicate discs for every single treatment. 
 
Harvesting and determination of colony forming units 
After 64.5 h, the biofilms were dip-washed in saline as described above to remove 
loosely adherent bacteria. Then the surface of each disc was scraped with a plastic scaler 
(KerrHawe SA, CH-6934 Bioggo, Switzerland) to remove the entire biofilm and the cells 
were collected in 1 ml saline. The cell suspension was then sonicated (5 s, 30 W) and aliquots 
were plated out using a spiral diluter. Total CFUs were assessed on Columbia Blood Agar 
plates. Total streptococci and all streptococcal species were assessed on Mitis Salivarius Agar 
(Difco). Columbia Blood Agar plates were incubated anaerobically and Mitis Salivarius Agar 
plates in 10% CO2 at 37 ºC. After 72 h of incubation, all CFUs were counted under a 
stereomicroscope and the results were expressed as total CFUs, total streptococci CFUs, S. 
oralis CFUs and S. mutans or S. sobrinus CFUs. In order to allow a comparison of the polyol 
treatments between biofilms containing different MS strains, the results were expressed as 
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delta CFUs, calculated by the difference in CFUs between each polyol treatment and its 
respective control group.  
 
Statistics 
Descriptive statistics of the data were performed with StatView 5.01 (SAS Institute, Cary, 
NC, USA) and illustrated with box plots. The log10-transformed data met the requirements for 
parametric analysis. Hence differences between treatments were analyzed by ANOVA 
followed by the Scheffe test (significance level p < 0.05).   
 
Results 
In total, eight mixed-six-species biofilms were grown in the present study, each one 
containing only one of the eight MS strains listed in table 1. Xylitol did not inhibit growth of 
any of the X-S or X-R MS strains tested in mixed-six-species biofilms whether it was 
provided before or after feeding (tables 2-5, fig. 3).  
In the presence of the X-S MS strain S. sobrinus ATCC 27352 in mixed-species 
biofilms, higher S. sobrinus counts were found in biofilms treated with sorbitol after feeding 
than in biofilms from the control group (table 2). The biofilms containing the S. mutans CM7 
X-S strain and treated with sorbitol after feeding, showed higher total CFUs and higher total 
streptococci CFUs when compared to controls or to biofilms treated with xylitol before 
feeding. These biofilms also showed higher S. mutans CFUs than the controls and the 
biofilms exposed to xylitol before or after feeding. In addition, exposure to sorbitol after 
feeding resulted in lower counts of S. oralis compared to the administration of sorbitol before 
feeding (table 2).  
In biofilms harbouring the X-R mutans strains no effect of polyols was observed, 
except in presence of the CM7 X-R strain where the biofilms treated with sorbitol after 
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feeding showed higher counts of S. mutans and lower counts of S. oralis compared to the 
other groups (table 3).     
With biofilms containing the fresh isolates of S. mutans (P-03 and M-51), no polyol 
effect was observed, except for the one on M-51 positive biofilms, which showed 
significantly reduced counts of S. oralis when treated with sorbitol after feeding (table 4). No 
polyol effects on total CFUs, total streptococcal CFUs and S. oralis CFUs were observed in 
the presence of the laboratory reference strains OMZ 176 (S. sobrinus) or OMZ 918 (S. 
mutans) in mixed-species biofilms (table 5). However, higher counts of OMZ 918 were found 
in biofilms treated with sorbitol after feeding in comparison to biofilms exposed to xylitol 
after feeding (table 5).  
Considering the delta CFUs values, with one exception no polyol effect on biofilms 
was observed.  The exception concerns biofilms treated with sorbitol after feeding, whereby 
higher delta MS counts were found compared to the xylitol treatment before feeding (fig. 3). 
 
Discussion 
The present study was undertaken to test the hypothesis that the “futile xylitol cycle” 
could explain the postulated reduction of MS in dental plaque. The hypothesis stems from 
experiments with planktonic cells in monospecies cultures. This question was addressed using 
an oral polyspecies biofilm model simulating the meal pattern of man [van der Ploeg and 
Guggenheim, 2004; Thurnheer et al., 2006].  
The mixed biofilms' response pattern to the four polyol treatments was similar for all 
eight MS strains tested (tables 2-5; fig. 3). With all treatments, differences in MS counts were 
minute, fluctuating mostly within one log-step. Expectedly, some variability in the ability of 
the MS strains to colonize the biofilms was found. The X-R strains colonized at a slightly 
lower level than the X-S strains, while the accompanying competing S. oralis strain was 
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favoured (tables 2, 3). The freshly isolated MS strains colonized the biofilms in higher 
numbers than the laboratory strains, at the expense of S. oralis (tables 4, 5).  
 The anticariogenic effect of xylitol has been claimed by many authors to be based on 
a reduction of MS in dental plaque [Söderling et al., 1989; Tanzer, 1995; Trahan, 1995; 
Mäkinen et al., 2005]. The present findings do not support that xylitol reduces MS counts in 
biofilms (tables 2-5, fig. 3). Further, conflicting data have been published and the clinical 
relevance of a reduction of the intra-oral load of MS is not clear [Beighton, 2005]. Not all 
studies concur with a mutans-reducing effect of xylitol [Birkhed et al., 1979; Giertsen et al., 
1999; Van Loveren, 2004]. Short-term and long-term clinical studies with different designs, 
administration form, and dosage of xylitol show disparate findings [Van Loveren, 2004]. It 
should also be noted that there is no consensus as to an efficient or minimal “therapeutic” 
dose of xylitol [Van Loveren, 2004]. The concentration of xylitol used in the present study, 
and the repeated, limited time periods of exposures of biofilms to xylitol simulated the daily 
consumption or topical application of xylitol-containing products. 
The energy-consuming futile cycle held responsible for the inhibitory effect of xylitol 
on MS involves uptake of xylitol via induction of a constitutive fructose-specific 
phosphotransferase transport system (PTS) [Assev and Rølla, 1984; Trahan et al., 1985; 
Assev and Rølla, 1986]. As a result, it was postulated that accumulated xylitol 5-phosphate 
will compete with phosphofructokinase and then arrest glycolysis by intracellular 
accumulation of glucose 6-phosphate [Assev and Rølla, 1986]. However, this cycle has only 
been proven to operate under highly un-physiologic conditions. In in vitro studies, pure 
cultures of S. sobrinus were first deprived of other carbohydrate reserves by incubation for 3 h 
with high concentrations of xylitol, whereupon the transport of only trace amounts of glucose 
was determined [Assev and Rølla, 1986]. Similarly, the formation of xylitol 5-phosphate in 
dental plaque was detected only after plaque samples had been incubated in vitro with xylitol 
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as the sole external carbohydrate source for 6 h [Wåler, 1992]. Thus, the bacteria had to grow 
under these conditions in order to induce the expression of the proteins necessary for this 
transport system, and the glucose concentration in the environment had to be very low in 
order to avoid catabolic repression [Carlsson, 1978]. Such conditions never prevail in the oral 
cavity and may also explain why xylitol did not inhibit MS under the present experimental 
conditions. Even after overnight starving, the concentrations of glucose in biofilms were 
obviously still sufficient to suppress the uptake of xylitol. Notably, to confirm the 
antimetabolic effect of xylitol in vivo intracellular accumulation of glucose 6-phosphate has 
not been demonstrated [Giertsen et al., 1999].  
Thus, one may question whether oral microorganisms will, in fact, take up xylitol 
under in vivo conditions. The fructose-specific PTS has an anticipated Km for xylitol of 
54 mM in contrast to 27 µM for fructose [Trahan et al., 1991], indicating that not until 
fructose levels are very low will xylitol be transported into X-S cells. The same holds for 
glucose. Glucose and fructose are the preferred hexoses of microorganisms. In saliva, glucose 
is always present at concentrations between 5 and 40 µM [Kelsey et al., 1972]. The 
concentration of glucose varies in plaque and due to enzymatic breakdown of extracellular 
glucans is most probably higher during “starvation” periods [Hotz et al., 1972]. Moreover, 
during food intake – as mimicked under the present experimental conditions – the glucose 
concentration in plaque is high and the pH low, favouring transport via alternative transport- 
systems [Carlsson and Hamilton, 1994]. 
We observed a slight, but statistically significant increase in MS numbers when 
biofilms were exposed after feeding to sorbitol (tables 2-5; fig. 3). This increase was 
accompanied by a slight, but statistically significant decrease in the numbers of S. oralis, and 
in some cases was also reflected in raised numbers of total CFUs and total streptococci (tables 
2-5). It is well known that the majority of MS and lactobacilli, some Actinomyces sp., some 
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non-mutans streptococci, as well as other less frequently encountered oral microorganisms 
ferment sorbitol [Edwardsson et al., 1977; Havenaar et al., 1978; Kalfas and Edwardsson, 
1990]. The reduction of S. oralis cells may thus be explained by the ability of MS and A. 
naeslundii to ferment sorbitol, resulting in an ecological advantage for S. mutans or S. 
sobrinus leading occasionally to higher total CFUs and streptococci counts in the biofilms, 
rather than by a sorbitol-induced inhibition of S. oralis.  
The increased numbers of MS in biofilms exposed to sorbitol after feeding (tables 2-5, 
fig. 3) are in accordance with clinical studies reporting an increase in S. mutans counts in 
plaque following frequent consumption of sorbitol [Söderling et al., 1989] or frequent mouth 
rinses with a sorbitol solution [Kalfas et al., 1990]. Sorbitol is transported into bacterial cells 
using a phosphenol pyruvate (PEP)-dependent sorbitol PTS, resulting in intracellular 
accumulation of sorbitol 6-phosphate, which is then further converted to fructose 6-phosphate 
by sorbitol 6-phosphate dehydrogenase [Brown and Wittenberger, 1973; Slee and Tanzer, 
1983]. Both enzymes are inducible, and in planktonic monocultures they are readily repressed 
by low levels of glucose, as normally found in the mouth [Slee and Tanzer, 1983]. Based on 
the common conception that the genotypic and phenotypic expression profiles of bacteria 
growing in biofilms are different from their planktonic counterparts, it may be postulated that 
gene regulation in biofilms induces the expression of enzyme activities necessary to transport 
and metabolize sorbitol only in the presence of glucose. This is supported by our observation 
that the sorbitol-induced increase in MS numbers was only discernible in biofilms when 
starved cells were exposed to sorbitol after feeding, indicating that the expression of this 
enzyme cascade in biofilms may in fact depend on a sufficient intracellular level of glucose. 
However, the slight increase in MS numbers occasionally observed in vivo and previously 
explained by adaptation to sorbitol is considered to be clinically insignificant [Birkhed and 
Bär, 1991; Bowen, 1996]. Fermentation of sorbitol is slow [Havenaar et al., 1978; Yamada et 
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al., 1985; Kalfas et al., 1990], resulting in pH drops in plaque above values that may cause 
dental caries [Birkhed and Edwardsson, 1978; Birkhed et al., 1979]. In contrast, glucose and 
sucrose in excess are rapidly catabolized mainly to lactate [Geddes, 1975; Carlsson and 
Hamilton, 1994]. Moreover, sorbitol does not promote plaque formation and adherence by 
synthesis of extracellular polysaccharides [Havenaar et al., 1978].  
Claims of superior effects over other polyols from using xylitol in a variety of 
products are often supported by reference to laboratory findings of xylitol effects on 
planktonic bacteria. However, as shown in the present study, caution should be taken when 
trying to extrapolate from such un-natural conditions to possible events taking place in 
biofilms on teeth in vivo. Discrepancies between the present and previous in vitro findings 
may be explained by the intermittent exposures of multispecies biofilms to xylitol used in our 
study, mimicking more realistic conditions of consumption, in contrast to the exposure used in 
studies with planktonic monocultures where xylitol was included in the fluid medium 
throughout the experiments giving totally unrealistic exposure times [Assev et al., 1983; 
Assev and Rølla, 1984; Assev and Rølla, 1986]. 
In summary, the present study showed no evidence of xylitol-induced reduction of the 
cell numbers of X-S, X-R, freshly isolated, or laboratory MS strains grown in a multi-species 
biofilm environment. Analogously, total streptococci, or total CFUs remained unaffected in 
spite of repeated and prolonged exposures before or after biofilm feeding to relatively high 
concentrations of xylitol. These findings do not support the hypothesis that xylitol reduces the 
numbers of MS in dental plaque by futile metabolic cycles.   
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Table headings  
Table 1. Mutans streptococci strains used in mixed-six-species biofilms. 
 
Table 2. Treatment effects on mixed-species biofilms containing a xylitol susceptible (X-S) 
mutans group strain. 
 
Table 3. Treatment effects on mixed-species biofilms containing a xylitol resistant (X-R) 
mutans group strain. 
 
Table 4. Treatment effects on mixed-species biofilms containing a freshly isolated S. mutans 
strain. 
 
Table 5. Treatment effects on mixed-species biofilms containing a laboratory reference strain 
of S. sobrinus or S. mutans. 
 
Figure legends 
Figure 1. Experimental arrangement and time flow of each biofilm experiment. 
 
Figure 2.  Schematic explanation of the allocation of biofilms to the different treatments in a 
single biofilm experiment. Each experiment was assigned one of the eight MS strains listed in 
Table 1. 
 
Figure 3. Box-plot diagram showing the delta CFUs of biofilms according to polyol 
treatments. 
Each box indicates the lower and the upper quartiles. Horizontal bars within boxes indicate median values. Data 
are based on eight distinct biofilm experiments.* Difference statistically significant by Scheffe test, p < 0.05. 
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Table 1. Mutans streptococci strains used in mixed-six-species biofilms 
Strains 
 
Feature 
Streptococcus mutans CM7 
 
xylitol sensitive (X-S)1 
Streptococcus mutans CM7 
 
xylitol resistant (X-R)1 
Streptococcus mutans P-03 
 
Fresh isolate 
Streptococcus mutans M-51 
 
Fresh isolate 
Streptococcus mutans OMZ 918 
(UAB159T, ATCC 700610T) 
 
Laboratory strain2 
Streptococcus sobrinus ATCC 27352 
 
xylitol sensitive (X-S)1 
Streptococcus sobrinus ATCC 27352 
 
xylitol resistant (X-R)1 
Streptococcus sobrinus OMZ 176 
 
Laboratory strain3 
 1 Strains kindly provided by Dr. Trahan, University of Quebec. 
 2 Strain acquired from ATCC. 
 3 Strain collection of the Section of Oral Microbiology, University of Zürich. 
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Table 2. Treatment effects on mixed-species biofilms containing a xylitol susceptible (X-S) mutans group strain  
 
 
 
Treatments 
 
S. sobrinus ATCC 27352 X-S strain 
 
 
S. mutans CM7 X-S strain 
Total 
CFUs 
 
Total 
streptococci 
CFUs  
 
  S. sobrinus 
 
S. oralis 
  Total 
  CFUs 
 
Total        
streptococci 
CFUs 
 
 S. mutans 
 
S. oralis 
Control 
 
9.0 ± 2.8 5.3 ± 1.3   0.6 ± 0.08*  4.6 ± 1.4   5.9 ± 1.9*    3.8 ± 0.6*   3.3 ± 0.3*   0.7 ± 0.3 
Xylitol before 
 
7.6 ± 2.1 6.4 ± 1.9   0.7 ± 0.2 5.4 ± 1.9   5.2 ± 0.9*    4.4 ± 0.7*   3.2 ± 0.8*  1.2 ± 0.1 
Xylitol after 
 
7.8 ± 0.6 4.7 ± 1.5   0.6 ± 0.2 4.0 ± 1.2    9.8 ± 1.9   6.0 ± 3.5   3.3 ± 2.0*  2.6 ± 1.7 
Sorbitol before 
 
7.0 ± 0.3 5.2 ± 0.3   0.6 ± 0.05 4.7 ± 0.5    6.6 ± 2.3   6.6 ± 2.5   4.6 ± 1.9  1.7 ± 1.0* 
Sorbitol after 
 
9.7 ± 0.5 5.3 ± 1.4   1.0 ± 0.1 3.5 ± 0.7  14.0 ± 3.2 15.0 ± 1.5 15.0 ± 2.0  0.4 ± 0.2 
Data are based on three separate biofilms and expressed as mean CFUs ± SD (x108). Significant differences (*) were observed only in comparison to the  
treatment "sorbitol after feeding", by Scheffe test (p < 0.05). 
 
 23 
 Table 3. Treatment effects on mixed-species biofilms containing a xylitol resistant (X-R) mutans group strain 
 
 
 
Treatments 
 
S. sobrinus ATCC 27352 X-R strain 
 
 
S. mutans CM7 X-R strain 
Total 
CFUs 
 
Total 
streptococci 
CFUs  
 
S. sobrinus 
 
S. oralis 
Total 
CFUs 
 
Total 
streptococci 
CFUs 
 
S. mutans 
 
S. oralis 
Control 
 
15.0 ± 2.9 9.8 ± 3.9   0.2 ± 0.1 9.4 ± 4.1 11.0 ± 3.2 11.0 ± 0.5 0.5 ± 0.04*   9.8 ± 0.2* 
Xylitol before 
 
10.0 ± 5.0 8.3 ± 5.0 0.07 ± 0.01 8.3 ± 5.0 14.0 ± 1.5 12.0 ± 1.5 0.5 ± 0.03* 10.0 ± 1.8* 
Xylitol after 
 
  9.7 ± 2.2 7.9 ± 3.8   0.1 ± 0.05 7.9 ± 3.8   8.9 ± 4.6   6.4 ± 1.9 0.7 ± 0.2*   5.6 ± 1.9* 
Sorbitol before 
 
  6.6 ± 2.2 4.3 ± 0.7 0.07 ± 0.01  4.1 ± 0.8 10.0 ± 3.3   9.0 ± 1.2 0.9 ± 0.2*   7.7 ± 0.8* 
Sorbitol after 
 
  7.3 ± 1.2 4.5 ± 0.7 0.07 ± 0.01 4.4 ± 0.7   9.0 ± 3.6   8.0 ± 4.3 7.8 ± 4.5   0.3 ± 0.3  
 Data are based on three separate biofilms and expressed as mean CFUs ± SD (x108). Significant differences (*) were observed only in comparison to the  
 treatment "sorbitol after feeding", by Scheffe test (p < 0.05). 
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  Table 4. Treatment effects on mixed-species biofilms containing a freshly isolated S. mutans strain 
 
 
 
Treatments 
 
Freshly isolated mutans P-03 strain 
 
 
Freshly isolated mutans M-51 strain 
Total 
CFUs 
 
Total 
streptococci 
CFUs 
 
S. mutans 
 
S. oralis 
Total 
CFUs 
Total 
streptococci 
CFUs 
 
S. mutans 
 
  S. oralis 
Control 
 
7.7 ± 1.4  7.2 ± 1.7  4.0 ± 0.5  3.2 ± 1.2  4.7 ± 2.5  4.5 ± 3.6  3.7 ± 3.2    0.4 ± 0.1* 
Xylitol before 
 
5.6 ± 2.4  2.7 ± 2.1  1.4 ± 1.4  1.4 ± 0.7  2.8 ± 1.4  2.1 ± 0.7 1.9 ± 0.6    0.2 ± 0.02* 
Xylitol after 
 
6.9 ± 1.9  5.2 ± 1.7 3.4 ± 0.6  1.9 ± 1.0  6.5 ± 1.6 7.3 ± 2.1  7.0 ± 2.0    0.4 ± 0.02* 
Sorbitol before 
 
6.3 ± 1.9  4.5 ± 1.1  2.7 ± 0.7  1.8 ± 0.4  6.3 ± 3.2  5.2 ± 1.6  4.9 ± 1.6    0.5 ± 0.1* 
Sorbitol after 
 
8.8 ± 1.9  7.3 ± 0.8  5.3 ± 0.7  2.1 ± 0.7  8.5 ± 1.2  6.4 ± 0.8  6.4 ± 0.8  0.02 ± 0.01  
 Data are based on three separate biofilms and expressed as mean CFUs ± SD (x108). Significant differences (*) were observed only in comparison to the  
 treatment "sorbitol after feeding", by Scheffe test (p < 0.05). 
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Table 5. Treatment effects on mixed-species biofilms containing a laboratory reference strain of S. sobrinus 
 or S. mutans. 
 
 
 
Treatments 
 
Laboratory sobrinus OMZ 176 strain 
 
 
Laboratory mutans OMZ 918 strain 
Total 
CFUs 
Total 
streptococci 
CFUs 
 
S. sobrinus 
 
S. oralis 
Total 
CFUs 
Total 
streptococci 
CFUs 
 
S. mutans 
 
S. oralis 
Control 
 
2.7 ± 0.4  1.1 ± 0.1  0.5 ± 0.3  0.6 ± 0.3  6.2 ± 1.2  1.9 ± 0.2  1.2 ± 0.3  0.7 ± 0.1  
Xylitol before 
 
2.6 ± 0.1  1.4 ± 0.4  0.4 ± 0.3  0.9 ± 0.1  4.9 ± 1.8  1.4 ± 0.3 0.8 ± 0.1  0.5 ± 0.3  
Xylitol after 
 
1.9 ± 0.6  0.7 ± 0.2  0.5 ± 0.2  0.2 ± 0.04  4.9 ± 1.6  1.2 ± 0.2  0.7 ± 0.2* 0.5 ± 0.1  
Sorbitol before 
 
2.6 ± 0.8  1.1 ± 0.3  0.4 ± 0.05  0.7 ± 0.2  3.1 ± 1.6  1.7 ± 1.4 1.2 ± 0.7  0.4 ± 0.5  
Sorbitol after 
 
1.9 ± 0.8  1.2 ± 0.2  0.8 ± 0.1  0.3 ± 0.1  4.0 ± 0.8  2.1 ± 0.2  2.0 ± 0.2  0.4 ± 0.1  
Data are based on three separate biofilms and expressed as mean CFUs ± SD (x108). Significant differences (*) were observed only in comparison to the  
treatment "sorbitol after feeding", by Scheffe test (p < 0.05). 
 
 
 
Biofi lms were grown in saliva except for 45 min feeding periods (7) at time: 
Exposures of biofi lms to xylitol, sorbitol or saliva (control) 
before or after feeding periods lasting 20 min at time:
Time 0 324 368 4012 4416 4820 5224 5628 60 64 hours
Discs anaerobically 
incubated at 37ºC 
in processed saliva
Polyol treatment 
before feeding
Discs 1-3: Saliva control
Discs 10-15: Incubation in 
saliva continued
Polyol treatment:
Discs 4-6: 7.5% xylitol 
Discs 7-9: 7.5% sorbitol
Anaerobically incubated 
during 20 min at 37ºC
Biofi lm feeding 
glucose / sucrose
All biofi lms fed and
anaerobically incubated 
during 45 min at 37ºC
Polyol treatment 
after feeding
Discs 1-3: Saliva control
Discs 4-9: Incubation in saliva
Polyol treatment:
Discs 10-12: 7.5% xylitol 
Discs 13-15: 7.5% sorbitol
Anaerobically incubated 
during 20 min at 37ºC
Discs anaerobically 
incubated at 37ºC 
in processed saliva
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